Form 8-K - Current report:
SEC Accession No. 0001125345-25-000087
Filing Date
2025-06-10
Accepted
2025-06-10 07:02:42
Documents
14
Period of Report
2025-06-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20250609.htm   iXBRL 8-K 31379
2 EX-99.1 exhibit991sagardrpapressre.htm EX-99.1 14227
6 GRAPHIC macrogenics20logo_jpgormat.jpg GRAPHIC 139164
  Complete submission text file 0001125345-25-000087.txt   359478

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20250609.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20250609_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20250609_pre.xml EX-101.PRE 12508
17 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20250609_htm.xml XML 2993
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 251035923
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)